Records containing: Psoriatic Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-01-10Vaccination in Patients With Inflammatory Rheumatic Diseases. The Impact of Anti-rheumatic Treatments on the Immunogenicity of Herpes-zoster Vaccine (Shingrix) and Protection Against Infection (HZ-REUMA)
-
CLINICAL_TRIALS study record update · 2024-12-27A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Patients With Active Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2024-12-20A Single Centre Prospective Cohort Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
-
CLINICAL_TRIALS study record update · 2024-12-12A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploratory Study to Evaluate the Effectiveness and Safety of SHR-1314 Injection in Adult Subjects With Active Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2024-12-06Title of Study: Eating Habits and Symptom Severity in Autoimmune Diseases: a Patient Survey
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-27A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Zunsemetinib vs Placebo in Patients With Moderate-to-Severe Active Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2024-11-27Evolution and Treatments of Chronic Inflammatory Systemic Diseases: Implementation of a Hospital Cohort in the Gastroenterology, Dermatology and Rheumatology Departments of the University Hospital of Besançon
-
CLINICAL_TRIALS study record update · 2024-11-21A Long-Term Extension Study to Demonstrate Safety of Tildrakizumab in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
-
CLINICAL_TRIALS study record update · 2024-11-12A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial Evaluating the Efficacy and Safety of SHR-1314 Injection in Adults With Active Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2024-10-23A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2024-10-16A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2024-10-15Impact of Air Pollution on the Course of Inflammatory Rheumatism: a Prospective, Single-center Study
-
CLINICAL_TRIALS study record update · 2024-10-09WORK-ON - Vocational Rehabilitation for People with Chronic Inflammatory Arthritis - a Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-10-04A NORwegian Randomized Strategy Trial in PsoRiatic Arthritis: ImagiNg Treat-to-target vs Conventional Treat-to-target
-
CLINICAL_TRIALS study record update · 2024-09-26Stronger Together Psoriatic Arthritis Wellness Study
-
CLINICAL_TRIALS study record update · 2024-09-25How Does PsAID Implementation Affect Treatment Intensification and Patient Satisfaction in PsA
-
CLINICAL_TRIALS study record update · 2024-09-19Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database (The FLYWAY Study)
-
CLINICAL_TRIALS study record update · 2024-09-19Do Patients With Skin PSoriasis Have Sub-clinical Features of ACTive Psoriatic Arthritis on Musculoskeletal UltraSound?
-
CLINICAL_TRIALS study record update · 2024-09-19IMPact of Inflammatory Arthritis on COVID-19 sTudy of the RAPPORT-ONTRAAC and FORCAST Rheumatic Disease Registries
-
CLINICAL_TRIALS study record update · 2024-09-19A Postmarketing, Multicenter, Longitudinal, Prospective, Pharmacokinetic, Phase 1B Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
-
CLINICAL_TRIALS study record update · 2024-09-04Cytokine Expression in Sera, Ex Vivo Stimulated Peripheral Blood Mononuclear Cells Culture, and Skin in Psoriasis - Comparison of Patients with and Without Joint Involvement
-
CLINICAL_TRIALS study record update · 2024-08-30Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology
-
CLINICAL_TRIALS study record update · 2024-08-27Korean Post-marketing Surveillance for Xeljanz(Registered) in Rheumatoid Arthritis and Psoriatic Arthritis Patients
-
CLINICAL_TRIALS study record update · 2024-08-09Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy in Patients With Rheumatologic Diseases: Comparison With Standard Management
-
CLINICAL_TRIALS study record update · 2024-07-19A Phase III Randomized, Double-blind, Placebo Controlled, Multicenter, Bridging Study of Subcutaneous Secukinumab, to Demonstrate Efficacy After Sixteen Weeks of Treatment and to Assess Safety, Tolerability and Long-term Efficacy Follow-up to One Year in Chinese Subjects With Active Psoriatic Arthritis